Cerity Partners LLC acquired a new position in shares of Afya Limited (NASDAQ:AFYA - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 26,568 shares of the company's stock, valued at approximately $476,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio grew its holdings in shares of Afya by 40.0% during the fourth quarter. Public Employees Retirement System of Ohio now owns 2,800 shares of the company's stock worth $44,000 after purchasing an additional 800 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Afya by 1,099.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 4,031 shares of the company's stock worth $64,000 after purchasing an additional 3,695 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Afya by 2,115.9% during the fourth quarter. JPMorgan Chase & Co. now owns 6,670 shares of the company's stock worth $106,000 after purchasing an additional 6,369 shares in the last quarter. Aquatic Capital Management LLC grew its holdings in shares of Afya by 47.6% during the fourth quarter. Aquatic Capital Management LLC now owns 9,300 shares of the company's stock worth $148,000 after purchasing an additional 3,000 shares in the last quarter. Finally, BNP Paribas Financial Markets purchased a new position in shares of Afya during the fourth quarter worth about $228,000. Hedge funds and other institutional investors own 88.02% of the company's stock.
Afya Price Performance
NASDAQ:AFYA traded down $0.16 during mid-day trading on Friday, reaching $14.47. The stock had a trading volume of 70,003 shares, compared to its average volume of 85,863. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.42 and a current ratio of 1.42. Afya Limited has a one year low of $14.41 and a one year high of $19.90. The firm has a 50 day moving average price of $17.28 and a two-hundred day moving average price of $17.36. The stock has a market capitalization of $1.36 billion, a P/E ratio of 10.96, a P/E/G ratio of 0.51 and a beta of 0.58.
Analyst Ratings Changes
AFYA has been the subject of several recent analyst reports. Wall Street Zen lowered Afya from a "buy" rating to a "hold" rating in a report on Saturday. UBS Group restated a "neutral" rating and issued a $19.50 target price (up previously from $17.50) on shares of Afya in a research report on Thursday, June 12th. Three investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $17.60.
Read Our Latest Stock Analysis on Afya
Afya Company Profile
(
Free Report)
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Recommended Stories

Before you consider Afya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.
While Afya currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.